HOME >> MEDICINE >> NEWS
Recreational use of an erectile dysfunction drug can be risky for some

Although the drugs used to treat Erectile Dysfunction, Sildenafil (Viagra), Tadalafil (Cialis) and Vardenafil (Levitra), have generally been proven safe, recreational use of these drugs is associated with higher risks of sexually-transmitted diseases (STD's), including HIV. In a study in the current issue of The American Journal of Medicine, researchers from the San Francisco Department of Public Health evaluated 14 studies of Sildenafil use among men who have sex with men (MSM).

Sildenafil users engaged in unprotected sex with partners of unknown HIV status from twice as often to almost six times as often as non-users. HIV-positive MSM were almost twice as likely to be diagnosed with an STD if they were also Sildenafil users and the newly HIV infected were 2.5 times as likely to be users.

Further complicating the situation, 54% of users mixed Sildenafil with other drugs to enhance the sexual experience. One study reported that 36% of all Sildenafil users combined its use with other drugs, including methamphetamines (23%), ecstasy (18%), poppers (15%), ketamine (11%), and GHB (8%). A study among MSM seeking STD clinic services in San Francisco found Sildenafil to be used concurrently with ecstasy (43%), methamphetamines (28%), and amyl nitrate (15%).

Writing in the article, Jeffrey D. Klausner, MD, MPH, suggests that "Focused action is needed to target this ongoing public health problem. Although the current evidence of association exists only for Sildenafil, likely due to the relatively recent approval of Tadalafil and Vardenafil, the needed action should focus on all three phosphodiesterase inhibitors (PDIs), as the observed associations with Sildenafil use most likely would occur with drugs of identical nature. The labeling for PDIs should be modified to warn users of an increased risk for STDs, including HIV infection. Educational programs, particularly among physicians, MSM, and methamphetamine users, should be implemented to increase a
'"/>

Contact: Pamela Poppalardo
p.poppalardo@elsevier.com
212-633-3944
Elsevier Health Sciences
26-May-2005


Page: 1 2

Related medicine news :

1. Smoking and obesity may increase the risk of erectile dysfunction
2. Studies to date say erectile dysfunction drugs affect other systems, mostly for the better
3. Use of statins shows improvement in erectile performance of some men
4. Men with erectile dysfunction have increased risk for cardiovascular events
5. Viagra improves urinary tract symptoms in men with erectile dysfunction
6. Vascular disease most common cause of male erectile dysfunction
7. Erectile dysfunction and lower urinary tract symptoms
8. Erectile dysfunction -- the canary in the mineshaft?
9. Stanford researchers identify immune dysfunction in melanoma patients
10. Erectile dysfunction drugs may trump nitroglycerin for heart protection
11. Erectile dysfunction influenced by race and ethnicity

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Recreational use erectile dysfunction drug can risky for some

(Date:11/18/2014)... Nov. 17, 2014 (HealthDay News) -- Hispanic women who,ve had ... a certain type of heart trouble than those who,ve had ... team of researchers led by Shivani Aggarwal of Wake Forest ... and older, from Chicago, Miami, New York City and San ... at least six children. A type of heart trouble ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... people on the verge of burning out are more likely ... suffering from so-called vital exhaustion -- a toxic combination of ... risk of developing heart disease, researchers report. "In our ... And I think, when that stress is left unchecked for ...
(Date:11/18/2014)... Dennis Thompson HealthDay Reporter ... Sierra Leone who became infected with Ebola in his native country ... Martin Salia had arrived Saturday at Nebraska Medical Center in Omaha. ... hospital in Sierra Leone,s capital city of Freetown. Sierra Leone, ... been ravaged by the Ebola outbreak that began last spring and ...
(Date:11/18/2014)... Randy Dotinga HealthDay Reporter ... use smartphone apps that help them track how many calories ... people who used a popular one after their doctor recommended ... conclusively debunk the idea of using such apps as weight-loss ... and their level of motivation varied, the researchers noted, and ...
(Date:11/17/2014)... 17, 2014 Vernon Brewer, Founder and President ... last two weeks and saw firsthand the devastating holocaust that ... in Iraq and Syria. , “‘Holocaust’ is not a term ... killed or driven thousands of Christians and members of other ... situation is desperate. As ISIS expands, they continue to ...
Breaking Medicine News(10 mins):Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 2Health News:Feeling 'Worn Out'? Your Heart May Pay the Price 3Health News:Doctor With Ebola Dies at Nebraska Hospital 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 2Health News:Calorie-Tracking Apps May Not Help You Lose Weight 3Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 2Health News:President of WORLD HELP Travels to Iraq and Jordan; Finds Religious Holocaust Being Executed by ISIS 3
(Date:11/18/2014)... Tocagen Inc. today announced that ... free survival at six months for recurrent high grade ... FC, compared to published benchmarks. HGG includes glioblastoma, the ... The data were delivered in an oral presentation at the ... of the Society for Neuro-Oncology (SNO) by Tim ...
(Date:11/17/2014)... CHARLOTTESVILLE, Va. , Nov. 17, 2014 HemoShear ... present at the 6th annual Partnering for Cures ... New York City . Marshall Summar , MD, ... Brian Wamhoff , PhD, Vice President of R&D and Co-founder ... of new rare disease treatments in less time and with ...
(Date:11/17/2014)... , Nov. 17, 2014   Wilson Therapeutics ... the start of a Phase 2 clinical study to ... WTX101 in Wilson Disease, a rare genetic disorder and ... to process copper. "We are delighted to ... patients as a next step in the development program ...
Breaking Medicine Technology:Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 2HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 3HemoShear and Children's National Health System to Unveil New Paradigm for Accelerating Rare Disease Drug Discovery 4Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 2Wilson Therapeutics Announces Start Of Phase 2 Study To Evaluate The Efficacy And Safety Of WTX101 In Newly Diagnosed Wilson Disease Patients 3
Cached News: